Atlas Trials

The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss

Clinical trial NCT02990403 · UNKNOWN

Trial details

NCT number
NCT02990403
Sponsor
Shanghai First Maternity and Infant Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Recurrent Pregnancy Loss
Start date
2014-10-01
Primary completion
2017-06-10
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.